Cargando…

The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy

PURPOSE: To present the clinical features of thyroid-associated ophthalmopathy (TAO) with different CT types, and to report the outcomes of endoscopic orbital decompression combined with fat decompression (EOD-FD). PATIENTS AND METHODS: Thirty-four patients with TAO who underwent EOD-FD between Dece...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yunyan, Hu, Feng, Ji, Yuanfei, Wang, Ruijun, Zhu, Kexuan, Kong, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186627/
https://www.ncbi.nlm.nih.gov/pubmed/37193956
http://dx.doi.org/10.1186/s12886-023-02957-7
_version_ 1785042599586824192
author Ye, Yunyan
Hu, Feng
Ji, Yuanfei
Wang, Ruijun
Zhu, Kexuan
Kong, Qiao
author_facet Ye, Yunyan
Hu, Feng
Ji, Yuanfei
Wang, Ruijun
Zhu, Kexuan
Kong, Qiao
author_sort Ye, Yunyan
collection PubMed
description PURPOSE: To present the clinical features of thyroid-associated ophthalmopathy (TAO) with different CT types, and to report the outcomes of endoscopic orbital decompression combined with fat decompression (EOD-FD). PATIENTS AND METHODS: Thirty-four patients with TAO who underwent EOD-FD between December 2020 and March 2022 in the Ophthalmology Department of Li Huili Hospital Affiliated with Ningbo University, were included in this retrospective interventional case series. Patients were categorized into two groups based on the results of computerized tomography (CT) scans: muscle expansion type and fat hyperplasia type. RESULTS: Thirty-four TAO patients (55 eyes) were included in this study, and the mean age was 38.62 years (range 22–60 years). The average eye protrusion (EP) reduced from preoperative 23.20 mm to postoperative 19.66 mm (p < 0.0001). Mean intraocular pressure (IOP) decreased from 20.11 mmHg at baseline to 17.29 mmHg postoperatively (p < 0.0001), with a reduction of 2.84 mmHg (14.12%). Twenty cases of muscle expansion and fourteen cases of fat hyperplasia were definite by CT imaging. The mean IOP in the muscle expansion group was higher than that in the fat hyperplasia group (p < 0.05). Elevated intraocular pressure (IOP) occurred in 23 eyes (36.11%), and it was associated with extraocular muscle involvement, gender, and EP. In 3 cases of impaired vision, the mean best corrected visual acuity (VA) improved from 0.4 preoperatively to 0.84 postoperatively (p < 0.01). There were 8 cases with visual field (VF) damage and/or corneal epithelium damage, and all these damages were reversible. CONCLUSION: In this study, we describe the clinical features and experience of EOD-FD in patients with TAO. EOD-FD is an effective technique in reducing IOP and proptosis, with a low incidence of postoperative diplopia.
format Online
Article
Text
id pubmed-10186627
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101866272023-05-17 The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy Ye, Yunyan Hu, Feng Ji, Yuanfei Wang, Ruijun Zhu, Kexuan Kong, Qiao BMC Ophthalmol Research PURPOSE: To present the clinical features of thyroid-associated ophthalmopathy (TAO) with different CT types, and to report the outcomes of endoscopic orbital decompression combined with fat decompression (EOD-FD). PATIENTS AND METHODS: Thirty-four patients with TAO who underwent EOD-FD between December 2020 and March 2022 in the Ophthalmology Department of Li Huili Hospital Affiliated with Ningbo University, were included in this retrospective interventional case series. Patients were categorized into two groups based on the results of computerized tomography (CT) scans: muscle expansion type and fat hyperplasia type. RESULTS: Thirty-four TAO patients (55 eyes) were included in this study, and the mean age was 38.62 years (range 22–60 years). The average eye protrusion (EP) reduced from preoperative 23.20 mm to postoperative 19.66 mm (p < 0.0001). Mean intraocular pressure (IOP) decreased from 20.11 mmHg at baseline to 17.29 mmHg postoperatively (p < 0.0001), with a reduction of 2.84 mmHg (14.12%). Twenty cases of muscle expansion and fourteen cases of fat hyperplasia were definite by CT imaging. The mean IOP in the muscle expansion group was higher than that in the fat hyperplasia group (p < 0.05). Elevated intraocular pressure (IOP) occurred in 23 eyes (36.11%), and it was associated with extraocular muscle involvement, gender, and EP. In 3 cases of impaired vision, the mean best corrected visual acuity (VA) improved from 0.4 preoperatively to 0.84 postoperatively (p < 0.01). There were 8 cases with visual field (VF) damage and/or corneal epithelium damage, and all these damages were reversible. CONCLUSION: In this study, we describe the clinical features and experience of EOD-FD in patients with TAO. EOD-FD is an effective technique in reducing IOP and proptosis, with a low incidence of postoperative diplopia. BioMed Central 2023-05-16 /pmc/articles/PMC10186627/ /pubmed/37193956 http://dx.doi.org/10.1186/s12886-023-02957-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ye, Yunyan
Hu, Feng
Ji, Yuanfei
Wang, Ruijun
Zhu, Kexuan
Kong, Qiao
The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
title The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
title_full The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
title_fullStr The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
title_full_unstemmed The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
title_short The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
title_sort outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186627/
https://www.ncbi.nlm.nih.gov/pubmed/37193956
http://dx.doi.org/10.1186/s12886-023-02957-7
work_keys_str_mv AT yeyunyan theoutcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT hufeng theoutcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT jiyuanfei theoutcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT wangruijun theoutcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT zhukexuan theoutcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT kongqiao theoutcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT yeyunyan outcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT hufeng outcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT jiyuanfei outcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT wangruijun outcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT zhukexuan outcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy
AT kongqiao outcomesofendoscopicorbitaldecompressioncombinedwithfatdecompressionforthyroidassociatedophthalmopathy